Today: 20 May 2026
AT&T stock slides to $23 ahead of earnings — what Wall Street is watching next
28 January 2026
2 mins read

AT&T stock slides to $23 ahead of earnings — what Wall Street is watching next

NEW YORK, Jan 27, 2026, 20:39 EST — The market has closed.

  • AT&T shares dropped roughly 2% Tuesday, closing near $23, just ahead of Wednesday’s earnings report.
  • With earnings approaching, the U.S. wireless group is under the spotlight for subscriber growth and its 2026 forecast.
  • The Fed’s Wednesday decision, along with upcoming peer earnings, may steer telecom stocks this week.

AT&T (T) shares slipped roughly 2% to $23.00 on Tuesday, then held steady in late trading as investors digested ahead of the carrier’s Q4 earnings release set for Wednesday. The stock traded between $22.96 and $23.55, with volume hitting around 72 million shares.

This report marks the first major earnings update for the U.S. wireless sector this season. Investors are focused on whether customer growth and cash flow can withstand fierce subscriber competition. Wall Street forecasts around 425,000 postpaid net phone additions—meaning new customers on monthly billed plans—and adjusted earnings of 46 cents per share on $32.9 billion in revenue, Barron’s noted. The next market move will likely hinge on guidance for 2026.

AT&T’s earnings call is scheduled for 8:30 a.m. ET Wednesday, according to its investor calendar—a timing that often triggers sharp stock moves. Investors will be focused on the 2026 outlook, particularly capital expenditures and free cash flow.

On Monday, Wells Fargo maintained its Overweight rating on AT&T but lowered the price target from $29 to $27, according to GuruFocus. This move added to the cautious mood ahead of the earnings report.

The bigger question for the sector is if carriers are sliding into a price war that might squeeze ARPU — average revenue per user. “I’m not really seeing a price war,” Jeff Moore, principal at Wave7 Research, told Fierce Network. Roger Entner, founder of Recon Analytics, called the worries over price wars “overblown.” Fierce Network

AT&T still needs to prove it can grow its subscriber base without resorting to steeper discounts. Signs of rising churn—the pace at which customers drop service—or falling margins would probably keep pressure on the stock.

Telecom stocks are also reacting to the rate narrative, as investors eye dividends and watch Treasury yields closely. The Federal Reserve will reveal its policy decision Wednesday at 2 p.m. ET, with a press conference set for 2:30 p.m.

The S&P 500 reached a record high Tuesday amid earnings season and the start of the Fed’s two-day meeting, according to a Reuters report. That rally has pushed many stocks to levels that seem to price in positive outcomes.

Verizon will release its fourth-quarter earnings on Friday, Jan. 30, with a webcast planned for 8 a.m. ET, the company announced.

T-Mobile’s investor page shows the Q4 2025 earnings call and a capital markets update scheduled for Feb. 11 at 8:30 a.m. ET.

AT&T faces a clear trigger: Wednesday’s earnings and the guidance tone, followed by the Fed’s announcement a few hours later. If either misses the mark, telecom shares could struggle to regain footing before Verizon wraps up the week with its report.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next
Previous Story

Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next

Carvana stock rises after Wells Fargo target hike, but options traders lean defensive
Next Story

Carvana stock rises after Wells Fargo target hike, but options traders lean defensive

Go toTop